Related Experiment Video
Updated: May 29, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
Bülent Koca1, Ozgür Kasapçopur, Süleyman Bakari
1Department of Pediatric Cardiology, Cerrahpasa Medical Faculty, İstanbul University, Istanbul, Turkey. bkoca78@yahoo.com
Insights
Juvenile idiopathic arthritis (JIA) in children does not show abnormal QT dispersion, a marker of heart rhythm. However, some patients exhibited early signs of diastolic dysfunction, indicating potential cardiac changes.
Area of Science:
- Pediatric Rheumatology
- Cardiology
- Clinical Electrophysiology
Background:
- Juvenile idiopathic arthritis (JIA) is a common childhood chronic inflammatory arthritis.
- Cardiac involvement, including pericarditis and myocarditis, is recognized in JIA.
- Left ventricular (LV) systolic and diastolic functions in pediatric JIA patients are understudied.
- QT dispersion (QTd) is a noninvasive marker for cardiac repolarization homogeneity and arrhythmogenicity, previously unexamined in JIA.
Purpose of the Study:
- To assess QT dispersion (QTd) and corrected QT dispersion (cQTd) in children with JIA.
- To evaluate the relationship between QTd/cQTd and LV systolic/diastolic function in pediatric JIA.
- To investigate potential arrhythmogenic markers in children with JIA.
Main Methods:
- Electrocardiography (ECG) and Doppler echocardiography were performed on JIA patients and controls.
- Measurements included QTmax, QTmin, QTd, corrected QT, cQTmax, cQTmin, and cQTd.
- Echocardiography assessed LV systolic and diastolic parameters, including flow velocities and relaxation times.
Main Results:
- No statistically significant differences in QTd or cQTd were observed between JIA patients and controls.
- Children with JIA showed abnormal diastolic function, characterized by increased late flow velocity, decreased early flow velocity, and prolonged isovolumic relaxation time.
- No ventricular arrhythmias were documented in either group during the 12-month follow-up.
Conclusions:
- QTd and cQTd do not appear to be significantly altered in children with JIA.
- Pediatric JIA patients may exhibit subclinical diastolic dysfunction.
- Further research is needed to understand the long-term cardiac implications of diastolic dysfunction in JIA.
Abstract:
Juvenile idiopathic arthritis (JIA) is the commonest cause of chronic inflammatory arthritis in childhood. Cardiac involvement as pericarditis, myocarditis and valvular disease is known to occur in patients with JIA (JIA), as it does in adults with rheumatoid arthritis. There are, however, few descriptions concerning systolic and diastolic functions of the left ventricle (LV) in children with JIA. QT dispersion (QTd) is simple noninvasive arrhythmogenic marker that can be used to assess homogeneity of cardiac repolarization and which has not been studied in JIA patients before. A recent study found that rheumatoid arthritis patients had an abnormally longer QTd and corrected QT (cQTd) dispersion, markers for ventricular arrhythmogenicity. This study assessed QTd and cQTd and their relation with systolic and diastolic function of the LV in a group of children with JIA. We performed electrocardiography and Doppler echocardiography on patients and controls. Maximum QT (QTmax), minimum QT (QTmin), QTd, corrected QT, maximum corrected QT (cQTmax), minimum corrected QT (cQTmin) and cQTd intervals were measured from standard 12-lead electrocardiography. No statistically significant differences were found between the groups in QTd and cQTd. Among the diastolic parameters, increased late flow velocity, decreased early flow velocity and prolonged isovolumic relaxation time reflected an abnormal relaxation form of diastolic dysfunction. During 12 months of follow-up, no ventricular arrhythmias were documented in either group.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Pericarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis I: Introduction
Rheumatic Heart Disease III: Medical Management